A phase 2 trial of bevacizumab and high-dose interferon alpha 2B in metastatic melanoma. (Q35050558)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase 2 trial of bevacizumab and high-dose interferon alpha 2B in metastatic melanoma. |
scientific article |
Statements
A phase 2 trial of bevacizumab and high-dose interferon alpha 2B in metastatic melanoma (English)
Thomas Olencki
Kiran Relekar
Cynthia Taylor
Amanda Kibler
Cheryl Kefauver
Lai Wei
Michael J Walker
Helen X Chen
Kari Kendra
William E Carson
1 reference
1 reference